ConductScience.org, home

Paper31502016

Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.

Lang JE and 2 others. Ann Surg Oncol, 2019. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2. Papers, record 31502016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31502016

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2.
PubMed
Journal
Ann Surg Oncol
PubMed
Year
2019
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.05
iCite
Revised in PubMed
2026-01-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lang JEJulie E
2Tseng WWWilliam W
3Kang IIrene

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Membrane ProteinsMajor topic
Neovascularization, PathologicMajor topic
Humans
Secreted Frizzled-Related Proteins

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA014089NCI NIH HHSUnited StatesP30CA014089PubMed and NIH
P30CA014089NCI NIH HHSUnited StatesP30CA014089PubMed and NIH

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,508,855Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29508855PubMed
212,689,940Synergy between tumor immunotherapy and antiangiogenic therapy.Blood2003https://conductscience.org/library/papers/12689940PubMed
319,458,075Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway.Cancer Res2009https://conductscience.org/library/papers/19458075PubMed
429,434,333Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29434333PubMed
520,554,717Angiogenesis inhibitors: current strategies and future prospects.CA Cancer J Clin2010https://conductscience.org/library/papers/20554717PubMed
628,808,589Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.J Adv Res2017https://conductscience.org/library/papers/28808589PubMed
721,435,468A novel function for programmed death ligand-1 regulation of angiogenesis.Am J Pathol2011https://conductscience.org/library/papers/21435468PubMed
819,581,909Adverse effects of anticancer agents that target the VEGF pathway.Nat Rev Clin Oncol2009https://conductscience.org/library/papers/19581909PubMed
94,938,153Tumor angiogenesis: therapeutic implications.N Engl J Med1971https://conductscience.org/library/papers/4938153PubMed
1024,482,243Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.Angiogenesis2014https://conductscience.org/library/papers/24482243PubMed
1126,171,757Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.Genes Chromosomes Cancer2015https://conductscience.org/library/papers/26171757PubMed
129,990,069Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/9990069PubMed
1326,905,812The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.Sci Rep2016https://conductscience.org/library/papers/26905812PubMed
1428,361,267Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?Angiogenesis2017https://conductscience.org/library/papers/28361267PubMed
1515,637,262Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.Science2005https://conductscience.org/library/papers/15637262PubMed
1625,987,985Preclinical mouse models of osteosarcoma.Bonekey Rep2015https://conductscience.org/library/papers/25987985PubMed
1717,602,073Bevacizumab 5 mg/kg can be infused safely over 10 minutes.J Clin Oncol2007https://conductscience.org/library/papers/17602073PubMed
187,972,041Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7972041PubMed
1921,941,296The parallel lives of angiogenesis and immunosuppression: cancer and other tales.Nat Rev Immunol2011https://conductscience.org/library/papers/21941296PubMed
2021,575,861High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A.Cancer Cell2011https://conductscience.org/library/papers/21575861PubMed

See all 29 references

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
EGF1,950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
KDR3,791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
PDCD15,133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
SFRP26,423PubTator's text mininghttps://conductscience.org/library/genes/6423NCBI Gene
VEGFA7,422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31502016

GET https://conductscience.org/api/papers/v1/31502016/references?page=2